Your browser doesn't support javascript.
loading
Finding the (biomarker-defined) subgroup of patients who benefit from a novel therapy: No time for a game of hide and seek.
McShane, Lisa Meier; Rothmann, Mark D; Fleming, Thomas R.
Affiliation
  • McShane LM; National Cancer Institute, Bethesda, MD, USA.
  • Rothmann MD; U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Fleming TR; University of Washington, Seattle, WA, USA.
Clin Trials ; 20(4): 341-350, 2023 08.
Article in En | MEDLINE | ID: mdl-37095696
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precision Medicine Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Clin Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precision Medicine Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Clin Trials Journal subject: MEDICINA / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: Country of publication: